Latest News

Strides Shasun receives USFDA approval for pain relieving drug

The US health regulator has provided its approval to Strides Shasun for Amantadine Hydrochloride tablets that are used in the treatment of Parkinson’s disease and Shingles to reduce pain.

Strides Shasun has said in a regulatory filing that “The product received approval in 15 months under the new GDUFA regime.”

It further said that “Strides Shasun…. has received approval from the USFDA for Amantadine Hydrochloride tablets 100 mg.”

Read EquityPandit’s Nifty Pharma Outlook for this week

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



πŸ“°
News
πŸ“ˆ
Prediction
πŸ“Š
FII / DII
πŸ‘”
Advisory
Get 1-2 Index Option Trades Daily